Medical Condition News

RSS

Physics-informed AI framework improves aortic aneurysm stress prediction

Ascending thoracic aortic aneurysms often progress silently, but once dissection or rupture occurs, they can cause severe mortality before hospital arrival or during admission.

4 Sep 2026

Psilocybin study explores new treatment for cocaine use disorder

Albert Arias, MD, chief of addiction psychiatry at Carilion Clinic, has received an award from the National Institute on Drug Abuse (NIDA) to research how psilocybin, a psychedelic compound being studied for several psychiatric and substance use disorders, can offer a new approach for people with cocaine use disorder.

4 Sep 2026

Gut bacterial molecule discovered to drive serious bile duct disease

Researchers at the University of Oslo and Oslo University Hospital have, together with international collaborators, discovered that a small molecule made exclusively by gut bacteria can actively drive disease in the bile ducts and worsen primary sclerosing cholangitis (PSC), a serious liver and bile duct disease.

4 Sep 2026

Tumor environments sculpt diverse natural killer cells for cancer therapies

For decades, natural killer (NK) cells have been classified into two main groups based on surface markers: one specialized for cytokine production and the other for direct killing.

4 Sep 2026

Community brain health programs successfully improve attention in older adults

As aging populations drive rising global healthcare demands, finding scalable ways to prevent cognitive decline has become a vital public health priority.

4 Sep 2026

Most oncology AI research overlooks critical patient safety and privacy

Flinders University researchers were part of an international team that conducted a scoping review that identified 2,441 records and found just 32 studies examined how cancer patients, survivors and carers feel towards generative AI being used in their care.

4 Sep 2026

Researchers find greater microplastic burden in lung cancer patients

People with lung cancer are more likely to have microplastics in their lungs and to have larger quantities of microplastics in their lungs, according to research that will be presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

4 Sep 2026

Pig kidney xenotransplantation offers a bridge for patients awaiting human donor kidneys

In January 2026, Tim Andrews, who had received a genetically edited pig kidney in January 2025, became the recipient of a human kidney.

3 Sep 2026

As life expectancy rises, healthy aging is more important than ever

Global disease burden is shifting toward aging-related conditions as people live longer, with these diseases now representing the largest expected lifetime health burden for newborns across all income groups. Modeling suggests that reducing aging-related disease could produce unusually large and progressively greater gains in both longevity and healthy life expectancy because improvements in survival and health reinforce one another.

3 Sep 2026

ACC Quality Summit 2026 to focus on cardiovascular patient care improvements

The American College of Cardiology (ACC) Quality Summit 2026 will take place on September 16-18 in Orlando, connecting the cardiovascular quality improvement community to share ideas, learn from real-world successes and drive measurable improvements in the quality, safety and value of patient care.

3 Sep 2026

Cancer-fighting T cells need small amounts of ROS to attack tumors, study finds

New research reveals a promising new target for treating cancer by harnessing a type of molecule previously thought to do more harm than good.

3 Sep 2026

Microscopic peptide droplets reduce colorectal tumor growth in mice

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing the growth of hard-to-treat colorectal tumours by about 67 per cent in mice.

3 Sep 2026

Increasing Canadian wildfires jeopardize critical care for dialysis patients

In the midst of another intense wildfire season, a new study sheds light on the risks they pose to life-sustaining dialysis care for thousands of Canadians.

3 Sep 2026

Cerebral palsy may be a trait rather than a disease

Historically, cerebral palsy (CP) was linked largely to events at birth, including prematurity or temporary loss of oxygen to the brain, but research over the past decade has suggested that genetic factors contribute to CP in many children.

3 Sep 2026

IBD patients with family cancer history more likely to develop colorectal cancer

People with inflammatory bowel disease (IBD) who have several close relatives with colorectal cancer are significantly more likely to develop the disease themselves.

3 Sep 2026

Brain-protecting immune cells may actually drive Alzheimer's disease

Immune cells that normally protect the body from damage by attacking foreign or infected cells are found in the brains of patients with Alzheimer's disease and related disorders at much higher levels than in healthy brains.

3 Sep 2026

Too little or too much testosterone may matter for heart rhythm

A review of clinical trials, observational studies, genetic analyses, and mechanistic research suggests that atrial fibrillation risk may follow a U-shaped relationship with testosterone, increasing at both low and high levels. Evidence on testosterone replacement therapy remains mixed, with researchers calling for prospective studies to determine whether mid-physiological testosterone targets and treatment formulation influence AF risk.

2 Sep 2026

Immigrants face longer ICU stays after stroke in Canada

Among people who have a stroke in Canada, immigrants were admitted to the intensive care unit (ICU) at similar rates as long-term residents or people who were born in Canada, but they were more likely to have longer stays in the ICU, according to a study published September 2, 2026, in Neurology, the medical journal of the American Academy of Neurology.

2 Sep 2026

High-dose folic acid appears safe from formaldehyde toxicity

Folic acid – an essential vitamin added to flour and cereals and prescribed at high doses for cancer patients and people with blood disorders – does not elevate toxic formaldehyde in the body, according to a new Cornell University study on mice and human cancer patients who consumed high doses.

2 Sep 2026

Daraxonrasib shows durable responses in RAS-mutant lung cancer

Daraxonrasib, an oral RAS inhibitor therapy, achieved durable responses in pretreated patients with RAS-mutant non-small cell lung cancer (NSCLC) in a Phase 1/2 trial led by The University of Texas MD Anderson Cancer Center.

2 Sep 2026